PROCARE HEALTH

Discover Menocare – Natural Relief for Menopause Symptoms Introducing Menocare, a natural and unique blend of Hops (Lúpulo) and Black Cohosh (Cimicifuga), specially formulated to help reduce hot flashes and night-time insomnia. Natural’s therapy are recommended by the Spanish Menopause Society (AEEM) as a first-line, 3-month natural therapy, Menocare has shown clinical effectiveness in supporting women’s well-being during menopause. Try Menocare today! Now available at all pharmacies and online: www.myfarmacare.com

PROCARE HEALTH vous invite à son premier webinar sur la #ménopause car « la ménopause n’est pas une fatalité ! » 📆 Mercredi 4 Juin 2025 🕦 19.30-20.30 👩💼Dr Lydia Marié-Scemama et Muriel Baccigalupo https://lnkd.in/dqK5kTZc #WomensHealth #SanteDeLaFemme #gynecologie #SageFemme

🚨 Just 4 Days Left to Register! 🚨 Join us for the upcoming EFC Webinar on: 🎥 Challenges and Dilemmas in Colposcopy 🗓️ Wednesday, 14 May 2025 🕖 7:00 PM CET Co-hosted with the Romanian Society of Colposcopy and Genital Inferior Tract Pathology, this webinar will explore real-world complexities, diagnostic grey areas, and the latest updates in colposcopic practice. 💶 Fees: • Trainees/Nurses – 15€ • Doctors – 20€ 🕑 Register by Monday, 12 May at 2:00 PM CET 👉 Register now to secure your spot: https://lnkd.in/eB7mgxhx This Webinar for Colposcopists is made possible thanks to the generous support of PROCARE HEALTH #efcwebinar #colposcopy #womenshealth #medicaleducationn #Gynaecologyy #continuingeducation

A fantastic moment of science exposure about Fertility. We are a company that is tremendously engaged into scientific investigation to help understand how we can improve ovocites quality and improve chance of pregnancy for women!! It really matters to us and we are committed to deliver!! Many thanks to Yosu Franco Iriarte, Silvia Iniesta, Dr Nicolás Mendoza, Carlos Dosouto Capel Antonio Forgiarini

A month of science, innovation and hope in reproductive health. NOTAS DE FERTILIDAD - NOTES OF FERTILITY In March, we were proud to host two major scientific events in Madrid and Barcelona, bringing together over 150 leading gynecologists and fertility experts. During these high-level sessions, Professor Nicolás Mendoza, Dr. Carlos Dosouto (Hospital Vall d’Hebron, Barcelona) and Dr. Silvia Iniesta (Hospital La Paz, Madrid) presented the latest scientific evidence and clinical studies supporting the superiority of Ovosicare Pro FIV as a nutritional supplement in IVF protocols — aimed at improving oocyte quality and implantation success. We also unveiled our clinical research roadmap, including future randomized controlled trials to continue building strong scientific foundations for our innovations. Dr. Yosu Franco (Ruber International, Madrid) offered a fascinating perspective on the role of artificial intelligence in oocyte selection — envisioning a future where data-driven algorithms reduce subjectivity and optimize embryo choice. Finally, Dr. Antonio Forgiarini (Next Fertility, Valencia) shared an inspiring case of a 40-year-old patient who, after 5 years of unsuccessful IVF attempts, was finally able to become a mother — thanks to Ovosicare Pro FIV supplementation. These events are part of our ongoing commitment to advancing fertility science. From all of us at Procare Health: thank you to the speakers, clinicians, and attendees who continue to support our shared mission — bringing new lifes into the world, backed by science. Enjoy the video of the Events!!

Siempre un placer escucharte hablar de calidad ovositaria y FIV! Gracias!🙏

**Procare Health se complace en anunciar que los últimos resultados del ensayo clínico Paloma II se han presentado en los principales congresos internacionales de ginecología durante los últimos seis meses. Estos hallazgos representan un avance significativo en el manejo de pacientes con infecciones por VPH de alto riesgo y lesiones cervicales.** Los resultados introducen un enfoque innovador que incorpora el **gel vaginal Papilocare®** como complemento a la estrategia actual de "esperar y ver". El ensayo clínico aleatorizado Paloma II demostró una impresionante **tasa de aclaramiento del VPH de alto riesgo del 88%** a los seis meses, mostrando una mejora estadísticamente significativa en comparación con el grupo de control. --- **Procare Health is delighted to announce that the latest results from the Paloma II clinical trial have been presented at major international gynecological congresses over the past six months. These findings represent a significant advancement in the management of patients with high-risk HPV infections and cervical lesions.** The results introduce a groundbreaking approach by incorporating **Papilocare® vaginal gel** into the current "wait and see" strategy. The randomized Paloma II clinical trial demonstrated an impressive **88% clearance rate of high-risk HPV** at six months, with a statistically significant improvement compared to the control group. #ProcareHealth #PalomaII #Papilocare #HPV #VPH #CervicalHealth #Gynecology #ClinicalTrial #HealthInnovation #WomensHealth

EUROGIN 2025 in beautiful Porto was another highly successful congress for Procare Health, full of energy and great vibes. The PALOMA 2 results were at the heart of our communication: Papilocare® is changing the paradigm in the treatment of HPV, with its new clearance data. Several abstracts, 2 oral communications, scientific event with 250 doctors, at least 500 HCPs who came to our booth and finally our annual face to face meeting with our affiliates and partners: our team couldn’t be busier and ended the congress with the feeling of a 'job well done'... The fight against HPV continues, day after day, event after event!   #eurogin2025 #procarehealth #fightinghpv #papilocare #innovation #paloma2

🌍 El #VPH afecta al 14% de las mujeres en España, y PROCARE HEALTH quiere cambiar esta realidad 👉 Con motivo del Día Internacional de Concienciación sobre el VPH (4 de marzo), Procare Health lanza la campaña "No esperes, actúa", una iniciativa de sensibilización sobre la prevención, el cribado y las opciones terapéuticas del virus del papiloma humano 📌 ¿Sabías que el 80% de las personas sexualmente activas contraerán el VPH en algún momento? Aunque en la mayoría de los casos el virus desaparece por sí solo, puede persistir y derivar en enfermedades graves, como el cáncer de cuello uterino 🔹 La campaña recorrerá varias ciudades europeas, incluyendo Madrid y Barcelona, para informar y generar conciencia. Habrá carteles, encuestas y entrevistas a ciudadanos sobre la importancia de la prevención y el tratamiento 💡 “No esperes, actúa” es un llamado a la acción para evitar la persistencia viral y permitir la regresión de las lesiones. ¡La información es clave para la prevención! 👉 Más información en: https://lnkd.in/dQDz_sF7 #VirusPapilomaHumano #SaludFemenina #DíaInternacionalVPH #NoEsperesActúa #Prevención #Concienciación